Dachaigh › Leukemia myeloid geur › Alabama › Birmingham
Sgrùdaidhean clionaigeach Leukemia myeloid geur ann an Birmingham, AL
Tha 21 sgrùdaidhean airson Leukemia myeloid geur a’ lorg phàirtichean aig làraichean ann agus timcheall air Birmingham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
A’ fastadhÌre 2
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
A’ fastadhÌre 1
- Children's Hospital of Alabama, Birmingham
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
A’ fastadhÌre 2
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A’ fastadhÌre 3
- University of Alabama at Birmingham, Birmingham
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
A’ fastadhÌre 2
- University of Alabama at Birmingham Cancer Center, Birmingham
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
A’ fastadhÌre 2
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
A’ fastadhÌre 3
- Children's Hospital of Alabama, Birmingham
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
A’ fastadhÌre 2
- University of Alabama - Birmingham, Birmingham
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
A’ fastadhÌre 3
- Children's Hospital of Alabama, Birmingham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
A’ fastadhÌre 1/2
- O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
A’ fastadhÌre 1/2
- Children's Hospital of Alabama, Birmingham
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
A’ fastadhÌre 2/3
- University of Alabama Birmingham, Birmingham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A’ fastadhSgrùdadh amharc
- University of Alabama at Birmingham, Birmingham
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
A’ fastadh
- University of Alabama at Birmingham, Division of Hematology and Oncology, Birmingham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
A’ fastadhÌre 2
- University of Alabama Birmingham, Birmingham
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
A’ fastadhÌre 1
- University of Alabama at Birmingham, Birmingham
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
A’ fastadhÌre 1
- University of Alabama O'Neal Cancer Center, Birmingham
HPC Offered for PRESERVE Expansion
A’ fastadhSgrùdadh amharc
- University of Alabama, Birmingham, Birmingham
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
A’ fastadhÌre 1/2
- The Kirklin Clinic of UAB Hospital, Birmingham
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
A’ fastadhFàilte do shaor-thoilich fhallain
- University of Alabama - Birmingham, Birmingham
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
A’ fastadhÌre 1
- University of Alabama at Birmingham, Birmingham
Sgrùdaidhean Leukemia myeloid geur ann am bailtean eile
- Houston, TX85 sgrùdaidhean
- New York City, NY51 sgrùdaidhean
- Boston, MA44 sgrùdaidhean
- Seattle, WA41 sgrùdaidhean
- Baldwin Park, CA40 sgrùdaidhean
- Columbus, OH35 sgrùdaidhean
- Philadelphia, PA34 sgrùdaidhean
- Durham, NC33 sgrùdaidhean
- Atlanta, GA31 sgrùdaidhean
- Tampa, FL29 sgrùdaidhean
- Chicago, IL26 sgrùdaidhean
- Portland, OR25 sgrùdaidhean
Sgrùdaidhean eile ann an Birmingham
- Aillse (gach seòrsa)31 sgrùdaidhean
- Aillse a' bhroilleach24 sgrùdaidhean
- Cancer Ovarian23 sgrùdaidhean
- Obesity23 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag22 sgrùdaidhean
- Myeloma iomaill18 sgrùdaidhean
- COPD17 sgrùdaidhean
- Galarachd Cardiovasculach17 sgrùdaidhean
- Diabaitis Seòrsa 216 sgrùdaidhean
- Ailse Endometrial16 sgrùdaidhean
- Ro-throm16 sgrùdaidhean
- Fibrosis Cystic16 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.